1. Introduction
===============

Understanding the modes of action of single compounds has been a challenging task. A single compound can elicit agonistic actions on one biological pathway but antagonistic responses on another pathway. Therefore, contradictory results can be obtained depending on the endpoint studied \[[@b1-ijms-13-15679],[@b2-ijms-13-15679]\]. Moreover, environmental pollution rarely exists as a single contaminant, resulting in many chances for multi-compound interactions. These interactions can strongly influence the effects of chemical stressors on organisms. There are considerable gaps in knowledge about the *in vivo* effects of toxic mixtures. Although a number of studies have investigated individual compounds of concern, exposure studies that focus on chemical mixtures are largely missing from the literature.

A number of toxico-genomic studies have invested large efforts towards a better understanding of mixture toxicity, but the complex interplay of toxicants among several biological pathways remains difficult to resolve \[[@b3-ijms-13-15679]--[@b5-ijms-13-15679]\]. Nevertheless, single-endpoint mixture studies generate valuable information, specifically when compound-related biomarkers are used (e.g., the loss of acetylcholinesterase activity in relation to organophosphate and carbamate pesticide exposure) \[[@b6-ijms-13-15679]\]. Acquiring in-depth information about the interactions of compounds requires techniques that can provide an overview of several endpoints and pathways simultaneously, such as proteomic approaches. Currently, only a limited number of studies have applied proteomics techniques to the evaluation of mixture toxicity responses.

The application of recent "omics"-technologies in (eco)toxicology depends on the assumption that all toxicologically relevant effects are accompanied by alterations in multiple genes or proteins. This application is particularly promising because classical chemical analyses can only quantify substances that are known in advance and are present in relatively high concentrations in the environment, but they cannot be used to assess environmental and biological conditions with respect to chemical bioavailability and the effects of toxicants *in vivo*. Therefore, the best "analyzer" of these complex effects on organisms is the exposed organism itself \[[@b7-ijms-13-15679]\]. *Dictyostelium discoideum* has been recognized as a model organism that can live on humus and decaying leaves, so it is widely exposed to toxicants in soils and could be a suitable biomonitoring organism for soil pollutants.

Nickel (Ni) is of great environmental concern; moreover, within a cell, its chemical form may be altered, and it exerts long-term harmful effects \[[@b8-ijms-13-15679]\]. It can be found naturally in metalliferous soils, but it is often found in the environment as a result of industrial discharges from electroplating, smelting, mining and refining operations, and other industrial emissions \[[@b9-ijms-13-15679]\]. Compared to other divalent metals, nickel toxicity has been studied mainly in water species \[[@b10-ijms-13-15679]--[@b12-ijms-13-15679]\]. A recent study monitored the expression of genes involved in the specific molecular response to nickel in a nickel-tolerant fungus \[[@b13-ijms-13-15679]\]. Although several toxicological studies have investigated the effects of Ni in various organisms, the underlying molecular mechanisms by which Ni causes cellular damage are poorly understood \[[@b14-ijms-13-15679]\]. Moreover, the cellular fate of nickel is interesting for phytoremediation applications, but the core mechanism of the molecules involved and the physiological conditions required, including soil absorption, neutralization and toxicity, remain elusive \[[@b15-ijms-13-15679]\].

Chlorpyrifos (CHP) is a broad-spectrum organophosphate pesticide with many urban and agricultural pest control applications. CHP forms the active ingredient in several insecticides and is among the most widely used insect control products \[[@b16-ijms-13-15679]\]. Poisoning from CHP could affect the central nervous system, cardiovascular system, and respiratory system; it also acts as a skin and eye irritant. The major and well-known toxic effects of CHP involve the nervous system, as CHP is an inhibitor of the enzyme acetylcholine esterase (AChE) \[[@b17-ijms-13-15679]\]; other possible toxic effects on environmentally important organisms are largely unknown. *D. discoideum* do not have a nervous system, and given the evidence of the activity of CHP against AChE \[[@b18-ijms-13-15679]\], this organism could be an appropriate model to study the underlying effects of CHP and other neurotoxic compounds on the proteome under conditions where other organisms would suffer from rapid mortality.

Numerous potential molecular targets for CHP (in addition to AChE) have been identified, including effects on macromolecule synthesis (DNA, RNA, and proteins) and oxidative stress and effects on microtubules \[[@b19-ijms-13-15679]--[@b24-ijms-13-15679]\].

Further information concerning the effects of nickel and CHP and their mixture on the cellular proteome is crucial for understanding the molecular mechanisms involved in their toxic effects and allows for further studies in biomonitoring, phytoremediation and toxicological sciences.

The aim of the present study is to characterize the toxic effects and the proteomic responses in the model organism *Dictyostelium discoideum* to CHP and nickel. Additionally, we compared the responses to the individual compounds with those of their binary equitoxic mixture using lysosomal membrane stability (LMS). The final objective was to evaluate the variation in the protein expression signature (PES) when cells are exposed to different concentrations of single compounds or a binary equitoxic mixture.

2. Results
==========

2.1. Experimental Design and Physiological Responses in *D. discoideum* Cells Exposed to Nickel, CHP and Their Mixture
----------------------------------------------------------------------------------------------------------------------

### 2.1.1. Mortality Rate

To evaluate the effect of the toxicants on cells, *D. discoideum* cells were exposed to increasing concentrations of NiCl~2~ (0--10.0 mM) and the organophosphate pesticide CHP (0--50 μM) for 3 h under laboratory conditions.

The first significant effects on mortality in *D. discoideum* (LOEC, low effect concentration) were observed after treatment with 0.75 mM NiCl~2~ ([Figure 1a](#f1-ijms-13-15679){ref-type="fig"}), while a significant increase in this parameter was induced after treatment with 10 μM CHP ([Figure 1b](#f1-ijms-13-15679){ref-type="fig"}).

### 2.1.2. Lysosomal Membrane Stability

After estimating the LOEC concentrations on *D. discoideum*, we used the parameter LMS to calculate toxicity endpoints (EC value) through a log-logistic regression, as described previously \[[@b25-ijms-13-15679]\]. The destabilization of lysosomal membranes represents one of the most sensitive stress response markers in eukaryotic cells, one that is often associated with increased autophagy, catabolism of macromolecules, and cellular injury \[[@b26-ijms-13-15679],[@b27-ijms-13-15679]\]. LMS was used to assess the toxicity of single compound treatments as well as their mixture. From the data plotted in [Figure 2](#f2-ijms-13-15679){ref-type="fig"}, we inferred two equitoxic doses for the single chemicals (EC25 and EC50) and one mixture at a nominal value of 1.0 TU, corresponding to EC50. According to the concentration addiction (CA) model \[[@b28-ijms-13-15679]\], the toxic unit of the mixture is obtained through the combination of NiCl~2~ EC25 and CHP EC25.

### 2.1.3. Endocytic Rate

Treatments of the single compounds at EC25 and EC50 and their mixture result in a negative effect on the rate of endocytosis of *D. discoideum* ([Figure 3](#f3-ijms-13-15679){ref-type="fig"}).

2.2. Effects of the Toxicants on the *D. discoideum* Proteome
-------------------------------------------------------------

### 2.2.1. Nickel

Treatment with 114.6 μM NiCl~2~ (EC25) induced changes in 14 protein spots, two of which were up-regulated ([Figure 4](#f4-ijms-13-15679){ref-type="fig"}, [Table 1](#t1-ijms-13-15679){ref-type="table"}). One down-regulated spot contained a mixture of dihydropteridine reductase, peroxiredoxin and an unknown protein, which prevents any quantitative evaluation and will not be discussed further.

NiCl~2~ treatment at EC50 (249.5 μM) showed a completely different PES with respect to the PES observed after the EC25 treatment, and the proteins with altered levels after the EC25 treatment returned to control levels after the EC50 treatment, showing a non-linear dose-response in protein levels. After treatment with NiCl~2~ at EC50, we observed the differential expression of 15 spots, five of which were up-regulated ([Table 2](#t2-ijms-13-15679){ref-type="table"}, [Figure 5](#f5-ijms-13-15679){ref-type="fig"}).

For one up-regulated spot that contained a combination of glutamate-ammonia ligase and prolyl oligopeptidase and two down-regulated spots that contained either *N*-acyl-[l]{.smallcaps}-amino-acid amidohydrolase and 26S proteasome non-ATPase regulatory subunit 6 or RepC-binding protein A and calreticulin, the quantitative changes in individual protein levels cannot be assigned to single proteins; therefore, they will not be discussed further.

### 2.2.2. Chlorpyrifos

The exposure of *D. discoideum* cells to 0.7 μM CHP (EC25) induced the down-regulation of six spots, as shown in [Table 3](#t3-ijms-13-15679){ref-type="table"} and [Figure 6](#f6-ijms-13-15679){ref-type="fig"}. Interestingly, cyclase-associated protein and glutamate ammonia ligase were also down-regulated by NiCl~2~ at the same equitoxic concentration (EC25).

The proteomic analysis after treatment with CHP at EC50 (9.6 μM) ([Table 4](#t4-ijms-13-15679){ref-type="table"}, [Figure 7](#f7-ijms-13-15679){ref-type="fig"}) revealed that additional and different proteins were modulated with respect to the EC25 treatment. Only the down-regulation of aldehyde dehydrogenase was common to the PESs of the two treatments, and there was a non-linear trend in the proteomics data for this compound. One spot appeared to be up-regulated, but after it was analyzed several times by mass spectrometry, we could not identify its constituent protein. The spot containing succinate dehydrogenase also contained an unknown protein that is likely to hamper any quantitative evaluation.

### 2.2.3. Mixture

The effects on the proteome after treatment with the equitoxic mixture indicated some overlap in the PES analyses for the single compounds for different proteins ([Table 5](#t5-ijms-13-15679){ref-type="table"}, [Figure 8](#f8-ijms-13-15679){ref-type="fig"}). In [Table 6](#t6-ijms-13-15679){ref-type="table"}, we reported the common proteins that change in some of the various treatments but with different trends. Interestingly, the levels of two different isoforms of *S*-adenosyl-methionine synthetase change in different treatments. The spots that changed in density after treatment with the mixture did not show comigrating proteins; in one case, we were unable to identify a down-regulated protein.

3. Discussion
=============

The mortality and lysosomal membrane destabilization caused by CHP and NiCl~2~ treatments in amoebae were evaluated to determine appropriate concentrations of both toxicants for further analyses. To evaluate the effects on mortality, various concentrations of CHP (0--50 μM) and NiCl~2~ (0--10 mM) were tested. LMS data were evaluated for CHP from 0 to 12.5 μM and for NiCl~2~ form 0 to 250 μM, which allowed us to evaluate the sublethal treatments that induce toxic or adaptive effects. For the single compounds, two experimental levels based on LMS data were tested and represented realistic (NiCl~2~ 114.6 μM; CHP 0.7 μM) and extreme (NiCl~2~ 249.5 μM; CHP 9.6 μM) scenarios. Moreover, a mixture of the two substances at equitoxic concentrations was assessed to obtain information about their interaction at the physiological and molecular levels.

The differentially expressed proteins were analyzed by Blast2GO for molecular processes and biological functions and the results can be found as [Supplemental File (Blast2GO Analysis)](#s3-ijms-13-15679){ref-type="supplementary-material"}.

3.1. Nickel
-----------

NiCl~2~ is not extremely toxic to *D. discoideum*, probably because of an energy-dependent nickel export that exists in wild-type and mutant strains, but its role in heavy metal resistance has not been confirmed \[[@b29-ijms-13-15679]\]. The mortality rate and lysosomal membrane destabilization data ([Figures 1](#f1-ijms-13-15679){ref-type="fig"} and [3](#f3-ijms-13-15679){ref-type="fig"}) revealed that the cytotoxicity increased with an increase in the NiCl~2~ concentration. Although the first effects on mortality were observed only after treatment with 0.75 mM NiCl~2~, at the subcellular level, LMS and proteomic data show effects at 10% of that concentration.

A concentration of 114.6 μM NiCl~2~, which corresponds to an EC25 for lysosomal membrane destabilization, was chosen for subsequent experiments. The sublethal effects at this concentration were evident, which might indicate that differential protein expression already occurs at this concentration. Moreover, after the sublethal treatments, amoebae could maintain a normal phenotype, which allowed us to extract sufficient amounts of proteins for 2DE experiments. A more toxic concentration of 249.5 μM of NiCl~2~, corresponding to EC50 for LSM, was chosen for comparison.

The data in [Table 1](#t1-ijms-13-15679){ref-type="table"} show that clear effects on the proteome can be observed after treatment with NiCl~2~ at EC25. Two proteins were up-regulated, succinate dehydrogenase and an isoform of *S*-adenosylmethionine synthetase (gi\|66803080). The activity of succinate dehydrogenase has been previously observed to be inhibited by cadmium, with the possibility of interfering with energy transport \[[@b30-ijms-13-15679]\]. *S*-Adenosylmethionine synthetase (SAM-S) catalyzes the biosynthesis of S-adenosylmethionine from Met and ATP. In plants, the expression of SAM-S is significantly altered in response to salt and drought \[[@b31-ijms-13-15679],[@b32-ijms-13-15679]\]. In yeast, the activity of this enzyme is strongly inhibited by heavy metal ions (Cu^2+^ and Ag^2+^) and ethylenediaminetetraacetic acid (EDTA). Moreover, the expression levels of SAM-S were markedly up-regulated in response to arsenate in rice roots \[[@b33-ijms-13-15679]\]. Unexpectedly, a different isoform of *S*-adenosyl-methionine synthetase (gi\|60463691) was down-regulated.

Cyclase-associated proteins (CAPs) are widely distributed and highly conserved proteins that regulate actin remodeling, vesicle trafficking and development in response to cellular signals \[[@b34-ijms-13-15679]\]. In *D. discoideum*, CAPs are essential for the functions of the endo-lysosomal system \[[@b35-ijms-13-15679]\]. This protein was down-regulated after treatment with CHP at EC25, and both NiCl~2~ and CHP EC25 treatments had the clearest effects on endocytosis. The effects on endocytosis are probably linked to the down-regulation of a subunit of the actin-related protein 2/3 (ARP2/3) complex, which plays a major role in actin cytoskeletal regulation.

Glutamate-ammonia ligase was recently identified as a nickel-binding protein by mass spectrometry, and its activity is inhibited by nickel \[[@b36-ijms-13-15679]\].

Rho GDP dissociation inhibitor (RhoGDI) plays an essential role in the control of a variety of cellular functions through its interactions with Rho family GTPases. RhoGDI is frequently over-expressed in human tumors and chemo-resistant cancer cell lines \[[@b37-ijms-13-15679]\]. The observed down-regulation due to NiCl~2~ could be of great interest and should be studied further.

The down-regulation of LIM-type zinc finger-containing protein after NiCl~2~ treatment is not surprising because low concentrations of transition metal have been shown to interfere with DNA transcription and repair. Various effects of heavy metals on zinc finger-containing proteins have been identified, including the displacement of zinc by cadmium or cobalt, the formation of mixed complexes, incomplete coordination of toxic metal ions, and the oxidation of cysteine residues within the metal-binding domain \[[@b38-ijms-13-15679]\].

The down-regulation of 60S acidic ribosomal protein P2, a ribosomal protein-like and elongation factor 1β, suggests a modulation in protein synthesis caused by the presence of nickel.

After comparing the results of the cytotoxicity tests and protein expression data, it can be seen that when the cells were treated with NiCl~2~ concentrations ranging from EC25 to EC50, the cytotoxic effects were linear, but different altered proteins were identified ([Tables 1](#t1-ijms-13-15679){ref-type="table"} and [2](#t2-ijms-13-15679){ref-type="table"}). These data indicate that NiCl~2~ toxicity cannot be quantitatively assessed by following the expression of single proteins in such a wide concentration range.

NiCl~2~ at EC50 induces different patterns of up-regulation, including an increase in the level of peroxiredoxin. The enzymes in this family consist of sulfhydryl-dependent peroxidases that exhibit high reactivity with hydrogen peroxide and play major roles in peroxide defense, redox cell signaling and metal responses \[[@b39-ijms-13-15679],[@b40-ijms-13-15679]\]. Peroxiredoxin has recently been found to have an increased expression in nickel-exposed workers \[[@b41-ijms-13-15679]\]. Nickel causes increased levels of endogenous cellular hydrogen peroxide and its short-lived reactive oxygen species \[[@b42-ijms-13-15679]--[@b44-ijms-13-15679]\].

Up-regulation of actin binding protein along with a modulation of the ARP2/3 complex and CAPs substantiates the involvement of the cytoskeleton in the cellular response to nickel. This up-regulation of cytoskeletal proteins in the EC50 treatment could explain the partial recovery of endocytic function. Accordingly, the up-regulation of AAA-ATPase domain-containing protein and a putative epimerase should be investigated further. There is little information about these two proteins, but a member of the AAA-ATPase family has recently been described as a novel anti-apoptotic factor in lung adenocarcinoma cells \[[@b45-ijms-13-15679]\].

We observed the down-regulation of different proteins after treatment with NiCl~2~ at EC50. Major vault protein (MVP), which is the main component of the vault complex, is over-expressed in many multidrug-resistant cancer cell lines, suggesting a possible role for MVP in cell signaling and survival \[[@b46-ijms-13-15679],[@b47-ijms-13-15679]\]. Vault complexes are implicated in the cellular response to environmental toxins, but we observed a reduction in the amount of this protein; thus, it is possible that NiCl~2~ does not activate this response pathway.

Glucose-regulated protein 94 is a member of the endoplasmic reticulum (ER) chaperone family. In *D. discoideum*, it is a constitutively expressed protein that is over-expressed in certain abnormal cellular conditions, including the depletion of glucose and calcium, low oxygen levels and low pH \[[@b48-ijms-13-15679]\]. We observed down-regulation of this protein after treatment with NiCl~2~ at EC50.

We observed the down-regulation of phosphoglycerate kinase after treatment with NiCl~2~ at EC50. The role of phosphoglycerate kinase in glycolysis is very important for the production of ATP through substrate level phosphorylation. Regulation of this protein is thereby controlled by the energy level of the cell.

Phosphoribosyl pyrophosphate synthetase (PRPS), which was also down-regulated, plays a key role in the biosynthesis of several amino acids and pyrimidines. PRPS is required to convert ribose 5-phosphate into phosphoribosyl pyrophosphate. The latter is a central compound for cellular metabolism and may be considered as a link between carbon and nitrogen metabolism.

NiCl~2~ induces the down-regulation of the cytosolic glycoprotein FP21 of *D. discoideum*, which is an orthologue of human and mouse *S*-phase kinase-associated protein 1. This protein is an essential component of the SCF (SKP1-CUL1-F-box protein) ubiquitin ligase complex, which mediates the ubiquitination of proteins involved in cell cycle progression, signal transduction and transcription.

We observed the down-regulation of the nascent polypeptide-associated complex alpha subunit. This protein prevents short, recently synthesized ribosome-associated polypeptides from inappropriate interactions with cytosolic proteins.

3.2. Chlorpyrifos
-----------------

The data show a toxic effect of CHP in *D. discoideum*, an organism that possesses no nervous system. CHP at 9.6 μM already induces the first lethal effects and 50% lysosomal membrane destabilization. Moreover, this compound exerts negative effects on endocytosis.

The proteomic data reveal that CHP at EC25 induces the down-regulation but not up-regulation of proteins. Cyclase-associated proteins are multifunctional proteins that contain several structural domains. Recent studies have suggested important roles for these proteins in linking cell signaling with actin polymerization and highlight their roles in vesicle trafficking and development, as discussed for NiCl~2~ at EC25.

We observed the down-regulation of the 26S proteasome ATPase 1 subunit. The ubiquitin/26S proteasome pathway is implicated in numerous diseases, including cancer and neurodegenerative diseases \[[@b49-ijms-13-15679]\]. The 26S proteasome regulatory complex has intrinsic ATPase activity that seems to play an essential role in its function. Presumably, one role of the ATPase is to supply energy continuously for the selective degradation of target proteins by the active 26S proteasome.

In bacteria, yeast and plants, glutamate-ammonia ligase (glutamine synthetase) expression is tightly regulated by the metabolic status of the cell \[[@b50-ijms-13-15679]\]. A previous study in freshwater crabs showed that glutamine synthetase activity increased after long-term organophosphate exposure \[[@b51-ijms-13-15679]\]. We observed the down-regulation of this enzyme, indicating that this protein is involved in the response to acute exposure to CHP in *D. discoideum*.

Isocitrate dehydrogenase (ICDH) catalyzes the oxidative decarboxylation of isocitrate. Eukaryotes possess two distinct types of ICDH: an NAD-specific enzyme (EC 1.1.1.41), which is present only in the mitochondria, and an NADP-specific enzyme (EC 1.1.1.42), which is found in both the cytoplasm and the mitochondria. The reduced activity of liver mitochondrial ICDH has been correlated with organophosphate toxicity \[[@b52-ijms-13-15679],[@b53-ijms-13-15679]\]. There is also evidence correlating the activities of ICDH and the maintenance of the cellular redox state, suggesting that ICDH plays an important role in cellular defenses against oxidative stress \[[@b54-ijms-13-15679]\].

Aldehyde dehydrogenase catalyzes the oxidation of various aldehydes, using NAD+ as a cofactor \[[@b55-ijms-13-15679]\]. The enzyme is inhibited by dithiocarbamate fungicides and has previously been described as a suitable detector for these pesticides in the environment \[[@b56-ijms-13-15679],[@b57-ijms-13-15679]\]. This enzyme is down-regulated by treatment with CHP at EC25.

Increased transcription of ZPR1-type zinc finger-containing protein has been observed in potato tuber periderm after heat stress \[[@b58-ijms-13-15679]\]. The deficiency of the zinc finger protein ZPR1 causes neuro-degeneration and defects in transcription in the mouse \[[@b59-ijms-13-15679]\] and cell cycle progression in HeLa cells \[[@b60-ijms-13-15679]\]. After treatment with CHP at EC25, we observed the down-regulation of this protein.

The EC50 treatment induces variations in the levels of different protein spots; two of these spots, which were up-regulated, contained two comigrating proteins. In one spot, we identified a tetratricopeptide-like helical domain-containing protein and stress-induced phosphoprotein 1. The other spot contained succinate dehydrogenase and an unknown protein. These spots, which contained comigrating proteins, give no quantitative information because it is impossible to establish which individual protein has altered levels.

The only protein that was down-regulated in both CHP treatments was aldehyde dehydrogenase, which is expected because this protein was previously found to act as a detector of pesticides in the environment \[[@b56-ijms-13-15679],[@b57-ijms-13-15679]\].

Among the up-regulated proteins, there is a putative iron regulatory protein (IRP) that acts as a key regulator of cellular iron homoeostasis as a result of the translational control of the expression of a number of iron metabolism-related genes. It is likely that various agents and conditions affect IRP activity, thereby modulating iron and oxygen radical levels in different circumstances \[[@b61-ijms-13-15679]\].

Previous studies have demonstrated that the up-regulation of transketolase (TKT) might play a critical role in maintaining a reducing environment in the mouse cornea \[[@b62-ijms-13-15679]\]. Moreover, in the cyanobacterium Anabaena, UV-B upregulated transketolase and protein down-regulation were observed with Cd treatment compared to a control treatment \[[@b63-ijms-13-15679]\]. The up-regulation that was observed in the present study suggests a role for this protein in the response to CHP.

Another protein that was up-regulated by CHP at EC 50 is annexin VII. Annexins belong to a large family of glycoproteins that bind both Ca^2+^ and negatively charged phospholipids and are considered important components of calcium signaling pathways \[[@b64-ijms-13-15679],[@b65-ijms-13-15679]\]. Various studies have shown that annexins play important roles in the cell during the response to oxidative stress \[[@b66-ijms-13-15679]--[@b68-ijms-13-15679]\]. The peroxidase activity that is exhibited by annexins is further exemplified by studies in plants \[[@b69-ijms-13-15679],[@b70-ijms-13-15679]\].

β-alanine synthase is an enzyme that catalyzes the final step of pyrimidine catabolism and is required for the biosynthesis of β-alanine in animals. In mammals, β-alanine is a natural antioxidant that is produced by the degradation of uracil or carnosin, which is a polypeptide that is formed by β-alanine and [l]{.smallcaps}-lysine. Moreover, β-alanine is necessary for the production of CoA, which is required for fatty acid metabolism. The treatment of *D. discoideum* cells with 9.6 μM CHP induced an increase in ROS production ([Figure S1](#s1-ijms-13-15679){ref-type="supplementary-material"}) with a simultaneous up-regulation of β-alanine synthase, which is the enzyme required for the production of β-alanine. Moreover, as described previously, we found the down-regulation of aldehyde dehydrogenase and *S*-adenosylmethionine synthetase (SAMS), both of which are needed in other mechanisms of β-alanine metabolism. We could hypothesize that the attempt by *D. discoideum* to modulate a specific pathway for β-alanine production is probably an alternative defense mechanism in response to the oxidative stress that is induced by pesticide treatment.

The expression levels of *S*-adenosylmethionine synthetase (SAMS) and a SAM-dependent methyltransferase are markedly up-regulated in response to arsenate in plants \[[@b33-ijms-13-15679]\]. Conversely, we observed the down-regulation of these proteins after CHP treatment at EC50. This difference requires further investigation.

We observed an increase in phosphopyruvate hydratase (also known as enolase), which is a metalloenzyme that is required for the penultimate step of glycolysis. Increased expression of enolase has recently been reported in stressed plants \[[@b71-ijms-13-15679]\].

The 60S ribosomal protein L4 is a component of the large ribosomal subunit. Yang *et al.* (2005) have show that this protein is required for rRNA processing in mammalian cells, and that decreasing the level of this peptide inhibits the production of several rRNAs \[[@b72-ijms-13-15679]\].

The exact physiological role of protein phosphatase 2C-like domain containing protein, which we found to be down-regulated after CHP at EC50 treatment, is unclear.

3.3. Mixture
------------

The results have demonstrated that each treatment results in different PESs, and the mixture gives a unique PES, making it difficult to apply PES to the toxicological evaluation of complex environmental matrixes. However, the data show that some proteins that have altered levels after the single toxicant treatments are involved in the cellular response to the mixture. The prominent protein in this class is cyclase-associated protein, which is down-regulated in both single treatments at EC25. Aldehyde dehydrogenase is down-regulated after treatment with CHP at EC25 but up-regulated by treatment with the mixture, along with aldehyde reductase, indicating an attempt by the cell to counteract the formation of lipid peroxide-derived aldehydes that are produced downstream of ROS \[[@b73-ijms-13-15679]\].

The down-regulation of G β-like protein indicates an involvement of G proteins in the response to the mixture. G proteins represent one of the most prevalent signaling systems in mammalian cells, regulating systems as diverse as sensory perception, cell growth and hormonal regulation.

Phosphoglycerate kinase catalyzes the reversible transfer of a phosphate group from ATP to 3-phosphoglycerate, producing ADP and 1,3-bisphosphoglycerate. This protein is down-regulated by CHP at EC50 but is up-regulated by the mixture.

*S*-adenosyl-methionine synthetase levels are altered by both NiCl~2~ EC25 and CHP EC50, and the protein was strongly up-regulated after treatment with the mixture; a putative δ-24-sterol methyltransferase that uses *S*-adenosyl-methionine as substrate was also up-regulated by the mixture.

Different cytoskeletal proteins, including actin binding protein, myosin II heavy chain, and clathrin heavy chain, were down-regulated by the mixtures, indicating the involvement of the cytoskeleton in the response to toxic substances, despite the fact that treatment with the mixture showed a partial recovery of the endocytic rate.

Isocitrate dehydrogenase (NAD+) levels were down-regulated by the mixture and by CHP at EC25. Aconitase (mitochondrial) has been established as a sensitive target of ROS, and the levels of this enzyme were down-regulated after treatment with the mixture.

ATP citrate synthase catalyzes the first reaction in the Krebs cycle, the conversion of oxaloacetate and acetyl-coenzyme A into citrate and coenzyme A. This reaction is important for energy generation and for carbon assimilation and was down-regulated by the mixture.

We observed the up-regulation of 3-phosphoglycerate dehydrogenase, which catalyzes the transition of 3-phosphoglycerate to 3-phosphohydroxypyruvate. This reaction is the first and rate-limiting step in the phosphorylated pathway of serine biosynthesis; serine is a constituent of proteins and a precursor of several metabolites, including cysteine, glycine and choline.

We observed the down-regulation of the pyruvate dehydrogenase E1 beta subunit. The pyruvate dehydrogenase complex is a nuclear-encoded mitochondrial multi-enzyme complex that catalyzes the overall conversion of pyruvate to acetyl-CoA and CO~2~ and provides a primary link between glycolysis and the tricarboxylic acid (TCA) cycle.

Another down-regulated protein was glucosamine-6-phosphate isomerase, which catalyzes the conversion of [d]{.smallcaps}-glucosamine 6-phosphate (GlcN6P) to [d]{.smallcaps}-fructose 6-phosphate and ammonia. This reaction is the last step in the pathway for *N*-acetylglucosamine utilization in bacteria or fungi.

Another interesting protein that was strongly up-regulated by the mixture was a putative transport protein that should be studied further to clarify its involvement in the response to the toxic mixture.

Based on these results, it is possible to investigate the molecular mechanisms of cytotoxicity on a proteomic scale by using a proteomic approach, despite the fact that each treatment has a different PES. In particular, this approach, beyond the simultaneous quantitative observation of proteins that are known to be stress responsive in a single experiment, allows us to identify novel proteins that have never previously been observed to change in level after toxic treatments.

4. Experimental Section
=======================

4.1. *Dictyostelium* Growth and Treatments
------------------------------------------

The social amoeba *Dictyostelium discoideum* (strain AX-2) was grown axenically in AX-2 medium as described previously \[[@b74-ijms-13-15679]\]. The cells were grown under laboratory conditions on a Gallenkamp orbital incubator (Sanyo Gallenkamp, Plc. Loughborough, UK) at 150 rpm and at 21 °C \[[@b75-ijms-13-15679]\]. To synchronize the cell cycle, the amoebae in logarithmic phase (2--4 × 10^6^ cells/mL) were stored overnight at 4 °C \[[@b76-ijms-13-15679]\]. The cell treatment was performed in diluted medium for 6 h as described previously \[[@b77-ijms-13-15679]\]. Chemicals of analytical grade were purchased from Sigma-Aldrich if not stated otherwise.

Nickel was administered as a chloride salt (NiCl~2~) from a concentrated stock solution (1000×), CHP was diluted in dimethylsulphoxide (DMSO) and added at the desired concentration from a concentrated stock solution (1000×). To exclude any effects of the DMSO vehicle, the same solvent volume was added to reference cells and NiCl~2~-exposed cells at the same dilution.

To evaluate the first significant effects on mortality in *D. discoideum* (LOEC), the cells were exposed to increasing doses of NiCl~2~ (0--10.0 mM) and CHP (0--50 μM).

After estimating the LOEC concentrations on the *D. discoideum* cells, we exposed the cells to increasing doses of NiCl~2~ (0--250 μM) and CHP (0--12.5 μM) to calculate toxicity endpoints (EC) using the parameter of lysosomal membrane stability (LMS).

For the proteomics studies and endocytic rate studies, *D. discoideum* cells were treated with two different equitoxic doses of the single chemicals---0.5 (EC25) and 1.0 (EC50) TU, and one mixture at a nominal 1.0 TU. According to the CA model \[[@b28-ijms-13-15679]\], these toxic levels are obtained through the combination of 2 × 0.5 TU. The cells were exposed to 114.6 and 249.5 μM NiCl~2~ and 0.7 and 9.6 μM CHP, which correspond to EC25 and EC50, respectively.

4.2. Mortality Rate, Lysosomal Membrane Stability and Endocytic Rate
--------------------------------------------------------------------

Biomarker assays were performed as described previously \[[@b77-ijms-13-15679]\]. Briefly, the mortality rate was assessed using the DNA-binding dye SYBR Green™ (Sigma-Aldrich, Milan, Italy), and observations of the cells were performed at 460× magnification on a Zeiss Axiovert 100M. For the evaluation of LMS, the retention times of neutral red (NRRT) dye in the lysosomes after exposure to several doses of pollutants were monitored.

Slides were observed at 1449× magnification in an inverted camera-equipped microscope (Zeiss Axiovert 100 M) that was controlled remotely via AxioVision software (Zeiss, Germany). For the endocytic rate, an aliquot of 40 μL cell suspension was incubated for 15 min with Fluorescent Bioparticles (*Escherichia coli* K-12 strain; Abs/Em maxim = 505/513 nm; Molecular Probes, Eugene, US). After incubation, *D. discoideum* cells were fixed in 3.7% paraformaldehyde and observed with a microscope at 1.449× magnification.

The images that were obtained from LMS and endocytosis were analyzed using an image analysis system (Scion Image freeware v 1.62) (Scion Corp., Frederick, MD, USA) that allowed the quantification of lysosomal Neutral Red (NR) and the quantification of fluorescent bacteria in the cells. The data were expressed as a percentage of the optical density with respect to the control condition. Data analysis was conducted using Winks SDA (ver. 6.0.5) statistics software (Texasoft, Duncanville, TX, USA). A non-parametric Mann-Whitney test was used to compare the control and treated samples. A statistical significance of *p* ≤ 0.05 is indicated as \*, and a statistical significance of *p* ≤ 0.01 is indicated as \*\*.

4.3. Cell Lysis and Protein Extraction
--------------------------------------

After treatments with several doses of nickel, CHP and their mixture, *D. discoideum* at a culture concentration of 45 × 10^6^ cells were washed twice with PAS, centrifuged at 500× *g*, precipitated and lysed in buffer (0.3% SDS, 200 mM DTT, 30 mM Tris, Protease Inhibitor Cocktail, P2714, Sigma-Aldrich, St Louis, MO, USAS) as described previously \[[@b74-ijms-13-15679]\]. Protein precipitation was performed in 80% (*v*/*v*) cold acetone in MilliQ water and centrifuged at 5000× *g* for 10 min.

After discarding the supernatant, the protein pellet was solubilized in a typical buffer for first-dimension isoelectric focusing (IEF) (7 M urea, 2 M thiourea, 4% *w*/*v* CHAPS, and 50 mM DTT).

4.4. 2-DE Gel Electrophoresis
-----------------------------

The proteins were extracted from seven biological replicates for each treatment and were separated by 2-DE gel electrophoresis (2-DE) according to a method described previously \[[@b74-ijms-13-15679]\].

For IEF, immobilized strip gels (pH 3--10 linear, 13 cm) (GE Healthcare Europe GmbH) were used to separate 800 μg of proteins. IEF was conducted at 20 °C on an IPGphor unit (GE Healthcare Europe GmbH).

For the second dimension, the focused proteins on the strips were reduced in an SDS equilibration buffer (50 mM Tris-HCl pH 8.8, 6 M Urea, 30% (*v*/*v*) glycerol, 2% (*w*/*v*) SDS) containing 10 mg/mL DTT for 15 min and subsequently alkylated with 25 mg/mL iodoacetamide for 10 min.

SDS-PAGE on 12% gels was performed in a Protean II XL 2-D cell (Bio-Rad Laboratories). The gels were fixed in a solution containing 40% (*v*/*v*) methanol and 10% (*v*/*v*) acetic acid in MilliQ water and stained with Colloidal Coomassie brilliant blue G250 (Bio-Rad Laboratories) according to Neuhoff *et al.*\[[@b78-ijms-13-15679]\]. Excess stain was removed by rinsing the gels with a solution containing methanol and acetic acid in MilliQ water.

4.5. Image Analysis
-------------------

The gels (3--10 pH) were scanned using a densitometer GS-710 (Bio-Rad Laboratories) and analyzed using PDQuestTM Software version 7.3.1 (Bio-Rad Laboratories), following the typical analysis workflow. The PDQuest matching summary is provided in [Supplemental Table 2](#s5-ijms-13-15679){ref-type="supplementary-material"}, and a typical 2DE map is presented in [Supplemental Figure 2](#s2-ijms-13-15679){ref-type="supplementary-material"}.

The relative abundance of each spot in the control and treated gels, obtained from seven biological replicates for each treatment, was performed by a software program using the Mann-Whitney U-test, and the differences were considered significant at *p* ≤ 0.05.

4.6. Automated ProteinSspot Picking and In-Gel Digestion
--------------------------------------------------------

The differentially expressed protein spots were transferred from gels to 96-well plates using a Proteome Works Spot Cutter (Bio-Rad Laboratories) (Richmond, CA, USA) that was equipped with a 1 mm diameter needle. For high-throughput identification by nanoHPLC-ESI-QTOF, the proteins were digested by trypsin (Roche Diagnostics, Monza, Italy) and extracted with Multiprobe II (Perkin Elmer, Wellesley, MA, USA) as described previously \[[@b74-ijms-13-15679]\].

4.7. Protein Identification by Nano-LC/Q-TOF MS/MS
--------------------------------------------------

The peptides samples that were obtained by in-gel digestion were vacuum dried and stored at −20°C until nano-high performance liquid chromatography (HPLC) ESI-Q-TOF MS/MS analysis.

Mascot.dll v 1.4804.0.22 (Matrix Science/AB Sciex) was used to generate Mascot (.mgf) files with peak lists from the Analyst QS 2.0 (.wiff) files; the default parameters were used.

The MS/MS spectra that were obtained by spot samples were analyzed as Mascot generic files against all entries in the public NCBInr database using the online Mascot program \[[@b79-ijms-13-15679]\] without a taxonomy filter.

The principal parameter settings for the Mascot search were as follows: database NCBInr (version 2012.04.07; 17751536 sequences) \[[@b80-ijms-13-15679]\]; enzyme trypsin; allow up to one missed cleavage; variable modifications carbamidomethyl (C), oxidation (M), deamidated (NQ); tolerances peptide ± 0.25 Da and MS/MS ± 0.25 Da; instrument ESI-QUAD-TOF; default charge state was set to 2+, 3+, and 4+. Only proteins with at least two peptides identified with significant ion scores (*p* ≤ 0.05) were considered as identified. Protein identification details are shown in [Table S1](#s4-ijms-13-15679){ref-type="supplementary-material"}.

5. Conclusions
==============

A large number of studies have focused on acute pollutant toxicity \[[@b81-ijms-13-15679]\]. The ability of *D. discoideum* to eliminate copper ions has been described previously \[[@b82-ijms-13-15679]\]. *D. discoideum* has been proposed as a model organism in toxicology \[[@b83-ijms-13-15679]\]. However, there is little information about the effects of toxic mixtures on the *D. discoideum* proteome.

We elucidated the proteomic responses of *D. discoideum* that were exposed to NiCl~2~, CHP and their mixture. It is likely that the direct use of PES requires much more data and more sensitive techniques to resolve the molecular mechanisms of the cellular responses to be routinely applicable to toxicity evaluations in environmental matrixes. There are obvious difficulties in understanding the biological complexity of the molecular mechanisms of the cell, and the technical procedures of the present study could be used to study the interactions between other mixtures and in other organisms. They could also be used to develop new methods to evaluate the toxicity of individual toxicants and their mixtures. The comparisons of the protein fingerprints of an equitoxic binary mixture and its single constituent compounds allows us to individuate additional molecular mechanisms that are switched on, which can be studied in the future with more specific approaches (e.g., the involvement of the cytoskeleton in toxic responses). Our study not only detected known pollutant-modulated proteins such as peroxiredoxins, aldehyde reductase and dehydrogenase, and *S*-adenosyl-methionine synthetase, which were observed previously \[[@b84-ijms-13-15679]--[@b86-ijms-13-15679]\], but also revealed significant changes in the levels of unknown proteins, such as a putative transport protein (gi\|166240434), that were strongly induced by the mixture but were never previously studied during a toxic response.
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![Two-dimensional gel electrophoresis (2-DE) gel portion of protein spots that are differentially expressed after treatment with 114.6 μM NiCl~2~ (EC25). The graph shows the ratio (% value) obtained by the PDQuest software (*p* ≤ 0.05, derived from the Mann-Whitney U-test). Protein identification details can be found in [Table 1](#t1-ijms-13-15679){ref-type="table"}.](ijms-13-15679f4){#f4-ijms-13-15679}

![2-DE gel portion of protein spots that were differentially expressed after treatment with 249.5 μM NiCl~2~ (EC50). The graph shows the ratio (% value) obtained using the PDQuest software (*p* ≤ 0.05, derived from the Mann-Whitney U-test). Protein identification details can be found in [Table 2](#t2-ijms-13-15679){ref-type="table"}.](ijms-13-15679f5){#f5-ijms-13-15679}

![2-DE gel portion of protein spots that were differentially expressed after treatment with 0.7 μM CHP (EC25). The graph shows the ratio (% value) obtained by the PDQuest software (*p* ≤ 0.05, derived from the Mann-Whitney U-test). Protein identification details can be found in [Table 3](#t3-ijms-13-15679){ref-type="table"}.](ijms-13-15679f6){#f6-ijms-13-15679}

![2-DE gel portion of protein spots that were differentially expressed after treatment with 9.6 μM CHP (EC50). The graph shows the ratio (% value) obtained by the PDQuest software (*p* ≤ 0.05, derived from the Mann-Whitney U-test). Protein identification details can be found in [Table 4](#t4-ijms-13-15679){ref-type="table"}.](ijms-13-15679f7){#f7-ijms-13-15679}

![2-DE gel portion of protein spots that were differentially expressed after treatment with the mixture (NiCl~2~ EC25 + CHP EC25). The graph shows the ratio (% value) obtained by the PDQuest software (*p* ≤ 0.05, derived from the Mann-Whitney U-test). Protein identification details can be found in [Table 5](#t5-ijms-13-15679){ref-type="table"}.](ijms-13-15679f8){#f8-ijms-13-15679}

###### 

Nickel EC25---identities of proteins with altered levels. Additional data can be found in [Table S1](#s4-ijms-13-15679){ref-type="supplementary-material"}.

  Spot n°   Protein ID                                     gi             DDB          Ratio (% value)
  --------- ---------------------------------------------- -------------- ------------ -----------------
  0013      60S acidic ribosomal protein P2                gi\|133059     DDB0191484   −45.3
  0106      LIM-type zinc finger-containing protein        gi\|7107412    DDB0201567   −55.7
  1108      Rho GDP-dissociation inhibitor                 gi\|66803106   DDB0216235   −55.5
  1115      Actin-related protein 2/3 complex, subunit 5   gi\|66806101   DDB0191138   −41.5
  3711      Glutamate-ammonia ligase                       gi\|60469746   DDB0231551   −35.6
  4106      Peroxiredoxin                                  gi\|28828367   DDB0231647   −31.2
            Dihydropteridine reductase                     gi\|66823097   DDB0237752   
  5108      Hypothetical protein DDBDRAFT_0206195          gi\|66815899   DDB0206195   −48.5
            Peroxiredoxin                                  gi\|66821043   DDB0231647   
  5412      *S*-adenosylmethionine synthetase              gi\|66803080   DDB0230070   83.8
  5718      Succinate dehydrogenase                        gi\|66813780   DDB0214886   61.2
  6106      Similar to ribosomal protein                   gi\|66821505   DDB0167610   −62.4
  6414      *S*-adenosyl-methionine synthetase             gi\|60463691   DDB0230070   −35.4
  7112      Hypothetical protein DDB_0233902               gi\|60475381   DDB0233902   −47.7
  7414      Elongation factor 1 β                          gi\|10801150   DDB0191174   −24.0
  7609      Cyclase-associated protein                     gi\|66805581   DDB0191139   −49.5

###### 

Nickel EC50---identities of proteins with altered levels. Additional data can be found in [Table S1](#s4-ijms-13-15679){ref-type="supplementary-material"}.

  Spot n°                                          Protein ID                                              gi             DDB          Ratio (% value)
  ------------------------------------------------ ------------------------------------------------------- -------------- ------------ -----------------
  0124                                             Putative polypeptide-associated complex alpha subunit   gi\|66812950   DDB0233328   −52.8
  0125                                             Cytosolic glycoprotein FP21                             gi\|66826197   DDB0191107   −52.0
  0526                                             RepC-binding protein A                                  gi\|4336714    DDB0191177   −50.1
  Calreticulin                                     gi\|66810606                                            DDB0191384                  
  0721                                             Glucose-regulated protein 94                            gi\|66814268   DDB0215015   −42.0
  1125                                             Nascent polypeptide-associated complex alpha subunit    gi\|66812950   DDB0233328   −18.1
  2334                                             *N*-acyl-[l]{.smallcaps}-amino-acid amidohydrolase      gi\|66825457   DDB0201767   −61.1
  26S proteasome non-ATPase regulatory subunit 6   gi\|66826503                                            DDB0232985                  
  2831                                             Hypothetical protein DDBDRAFT_0192196                   gi\|66799895   DDB0192196   −44.8
  3423                                             Phosphoglycerate kinase                                 gi\|22711882   DDB0191349   −40.4
  3721                                             Glutamate-ammonia ligase                                gi\|66815105   DDB0231551   42.3
  Prolyl oligopeptidase                            gi\|4584573                                             DDB0185041                  
  3826                                             Major vault protein                                     gi\|66825911   DDB0191259   −47.3
  4529                                             Actin binding protein                                   gi\|66827977   DDB0191115   112.9
  4732                                             AAA ATPase domain-containing protein                    gi\|66805423   DDB0231600   127.5
  6132                                             Peroxiredoxin                                           gi\|66808689   DDB0238212   109.2
  6218                                             Putative epimerase                                      gi\|66820416   DDB0167407   41.9
  6223                                             Phosphoribosyl pyrophosphate synthetase                 gi\|66809487   DDB0237882   −32.1

###### 

Chlorpyrifos EC25---identities of proteins with altered levels. Additional data can be found in [Table S1](#s4-ijms-13-15679){ref-type="supplementary-material"}.

  Spot n°   Protein ID                                 gi             DDB          Ratio (% value)
  --------- ------------------------------------------ -------------- ------------ -----------------
  3711      Glutamate-ammonia ligase                   gi\|60469746   DDB0231551   −52.2
  7609      Cyclase-associated protein                 gi\|66805581   DDB0191139   −37.4
  4613      26S proteasome ATPase 1 subunit            gi\|66826743   DDB0232964   −28.4
  6310      Isocitrate dehydrogenase (NAD^+^)          gi\|66799989   DDB0231294   −34.5
  4610      Aldehyde dehydrogenase                     gi\|66818493   DDB0231504   −28.1
  0605      ZPR1-type zinc finger-containing protein   gi\|66825227   DDB0304584   −47.0

###### 

Chlorpyrifos EC50---identities of proteins with altered levels. Additional data can be found in [Table S1](#s4-ijms-13-15679){ref-type="supplementary-material"}.

  Spot n°                                 Protein ID                                                                                       gi             DDB          Ratio (% value)
  --------------------------------------- ------------------------------------------------------------------------------------------------ -------------- ------------ -----------------
  1617                                    Protein phosphatase 2C-like domain-containing protein                                            gi\|66809891   DDB0233767   −29.1
  2723                                    not identified                                                                                   /              /            69.4
  3326                                    Putative SAM-dependent methyltransferase                                                         gi\|60475385   DDB0233903   −32.1
  3424                                    *S*-adenosylmethionine synthetase                                                                gi\|66803080   DDB0230070   −20.6
  3536                                    Aldehyde dehydrogenase                                                                           gi\|66818493   DDB0231504   −24.5
  3725                                    Tetratricopeptide-like helical domain-containing protein (TPR) stress-induced phosphoprotein 1   gi\|66801325   DDB0237783   59.1
  4432                                    β-Alanine synthase                                                                               gi\|66821393   DDB0185221   33.7
  4642                                    Transketolase                                                                                    gi\|66822027   DDB0266926   73.6
  4655                                    Succinate dehydrogenase (ubiquinone)                                                             gi\|66813780   DDB0214886   44.7
  Hypothetical protein DDBDRAFT_0218901   gi\|66807283                                                                                     DDB0218901                  
  4730                                    Putative iron regulatory protein                                                                 gi\|66815641   DDB0229908   60.5
  6523                                    Annexin VII                                                                                      gi\|66825303   DDB0191502   108.4
  7323                                    Phosphopyruvate hydratase                                                                        gi\|66811048   DDB0231355   125.8
  8432                                    60S ribosomal protein L4                                                                         gi\|66817212   DDB0231241   −54.4

###### 

Mixture EC25---identities of proteins with altered levels. Additional data can be found in [Supplemental Table 1](#s4-ijms-13-15679){ref-type="supplementary-material"}.

  Spot n°   Protein ID                                   gi              DDB          Ratio (% value)
  --------- -------------------------------------------- --------------- ------------ -----------------
  0510      Hypothetical protein DDBDRAFT_0187751        gi\|66806459    DDB0187751   −44.4
  1114      Pyruvate dehydrogenase E1 beta subunit       gi\|66818919    DDB0229442   −50.8
  1119      Putative delta-24-sterol methyltransferase   gi\|60464861    DDB0237965   −41.5
  2722      Clathrin heavy chain                         gi\|66818048    DDB0185029   −60.9
  2803      Myosin II heavy chain                        gi\|134047850   DDB0191444   −62.2
  3110      Aldehyde reductase                           gi\|38637654    DDB0215363   30.1
  3115      not identified                               /               /            −32.9
  3414      Aldehyde dehydrogenase                       gi\|66818493    DDB0231504   90.3
  3416      Phosphoglycerate kinase                      gi\|22711882    DDB0191349   44.8
  4613      Glucosamine-6-phosphate isomerase            gi\|66808101    DDB0234127   −30.6
  4615      Putative transport protein                   gi\|166240434   DDB0235163   132.4
  5208      Isocitrate dehydrogenase (NAD^+^)            gi\|60462281    DDB0231294   −52.7
  5307      *S*-adenosyl-methionine synthetase           gi\|60463691    DDB0230070   68.0
  5415      3-phosphoglycerate dehydrogenase             gi\|66813238    DDB0230052   43.3
  6016      Actin binding protein                        gi\|60468343    DDB0215335   −30.0
  6210      G β-like protein                             gi\|66820452    DDB0185122   −56.7
  6607      Cyclase-associated protein                   gi\|66805581    DDB0191139   −50.8
  6608      ATP citrate synthase                         gi\|66816585    DDB0235360   −44.7
  6612      Aconitase, mitochondrial                     gi\|60470010    DDB0230168   −37.5

###### 

Common proteins with altered expression levels after the various treatments. The variations in protein levels are expressed as percentages.

  gi             Protein ID                           Chlorpyrifos   Nickel   Mixture           
  -------------- ------------------------------------ -------------- -------- --------- ------- -------
  gi\|66805581   cyclase-associated protein           −37.4          /        −49.5     /       −50.8
  gi\|60469746   glutamate-ammonia ligase             −52.2          /        −35.6     /       /
  gi\|66818493   aldehyde dehydrogenase               −28.1          −24.5    /         /       90.3
  gi\|60463691   *S*-adenosyl-methionine synthetase   /              /        −35.4     /       68.0
  gi\|66803080   *S*-adenosylmethionine synthetase    /              −20.6    83.8      /       /
  gi\|22711882   phosphoglycerate kinase              /              /        /         −40.4   44.8
  gi\|60462281   isocitrate dehydrogenase (NAD+)      −34.5          /        /         /       −52.7
